Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes

Journal of Clinical Microbiology

Volumn 40, Issue 11, 2002, Pages 3999-4003

  Fernández Torres, Belkys ^a   Cabañes, Francisco J ^a   Carrillo Muñoz, Alfonso J ^a   Esteban, Alexandre ^a   Inza, Isabel ^a   Abarca, Lourdes ^a   Guarro, Josep ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CLOTRIMAZOLE; ITRACONAZOLE; TERBINAFINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; COLONY FORMING UNIT; CONTROLLED STUDY; DERMATOPHYTE; EPIDERMOPHYTON FLOCCOSUM; GROWTH INHIBITION; INCUBATION TIME; INOCULATION; MICROSPORUM CANIS; MICROSPORUM GYPSEUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAECILOMYCES; PRIORITY JOURNAL; REPRODUCIBILITY; TEMPERATURE; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CLOTRIMAZOLE; CULTURE MEDIA; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; REPRODUCIBILITY OF RESULTS; TEMPERATURE;

ARTHRODERMA BENHAMIAE; ARTHRODERMA GYPSEUM; ARTHRODERMATACEAE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANIS; EPIDERMOPHYTON FLOCCOSUM; MICROSPORUM; MICROSPORUM CANIS; PAECILOMYCES; TRICHOPHYTON; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 0036841462     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.11.3999-4003.2002     Document Type: Article

References (34)

1. Alou, L., J. R. Maestre, R. Moreno, et al. 2001. Consumo de antifúngicos de uso tópico en España. Rev. Esp. Quimioterap. 14:340-344.
2. Barchiesi, F., D. Arzeni, V. Camiletti, O. Simonetti, A. Cellini, A. M. Offidani, and G. Scalise. 2001. In vitro activity of posaconazole against clinical isolates of dermatophytes. J. Clin. Microbiol. 39:4208-4209.
3. Butty, P., J. C. Lebecq, M. Mallié, and J. M. Bastide. 1995. Evaluation of the susceptibility of dermatophytes to antifungal drugs: A new technique. J. Med. Vet. Mycol. 33:403-409.
4. Debruyne, D., and A. Coquerel. 2001. Pharmacokinetics of antifungal agents in onychomycoses. Clin. Pharmacokinet. 40:441-472.
5. de Hoog, G. S., J. Guarro, J. Gené, and M. J. Figueras. 2000. Atlas of Clinical Fungi, 2nd Ed. Centralbureau for Schimmelcultures, Utrecht, The Netherlands.
6. Denning, D. W., S. A. Radford, K. L. Oakley, L. Hall, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in vitro susceptibility testing to itraconazole and in vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-414.
7. Espinel-Ingroff, A. 2001. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J. Clin. Microbiol. 39:1360-1367.
8. Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob. Agents Chemother. 39:314-319.
9. Espinel-Ingroff, A., M. Bartlett, V. Chaturvedi, M. Ghannoum, K. C. Hazen, M. A. Pfaller, M. Rinaldi, and T. J. Walsh. 2001. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp: NCCLS collaborative evaluation. Antimicrob. Agents Chemother. 45:1828-1835.
10. Fernández-Torres, B., A. J. Carrillo, E. Martin, A. del Palacio, M. K. Moore, A. Valverde, M. Serrano, and J. Guarro. 2001. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob. Agents Chemother. 45:2524-2528.
11. Fernández-Torres, B., H. Vázquez-Veiga, X. Llovo, M. Pereiro, Jr., and J. Guarro. 2000. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole, and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 46:390-394.
12. Fernández-Torres, B., M. Pereiro, and J. Guarro. 2002. Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum. Eur. J. Clin. Microbiol. Infect. Dis. 21:70-71.
13. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a macrobroth antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
14. Gehrt, A., J. Peter, P. A. Pizzo, and T. J. Walsh. 1995. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J. Clin. Microbiol. 33:1302-1307.
15. Granade, T. C., and W. M. Artis. 1980. Antimycotic susceptibility testing of dermatophytes in microcultures with a standardized fragmented mycelial inoculum. Antimicrob. Agents Chemother. 17:725-729.
16. Guarro, J., I. Pujol, C. Aguilar, C. Llop, and J. Fernández-Ballart. 1998. Inoculum preparation for in-vitro susceptibility testing of filamentous fungi. J. Antimicrob. Chemother. 42:385-387.
17. Jessup, C. J., J. Warner, N. Isham, I. Hasan, and M. A. Ghannoum. 2000. Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J. Clin. Microbiol. 38:341-344.
18. Korting, H. C., M. Ollert, D. Abeck, and the German collaborative dermatophyte drug susceptibility study group. 1995. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob. Agents Chemother. 39:1206-1208.
19. Korting, H. C., M. Schäfer-Korting, H. Zienicke, A. Georgii, and M. W. Ollert. 1993. Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimicrob. Agents Chemother. 37:2064-2068.
20. Llop, C., I. Pujol, C. Aguilar, J. Sala, D. Riba, and J. Guarro. 2000. Comparison of three methods of determining MICs for filamentous fungi using different endpoint criteria and incubation periods. Antimicrob. Agents Chemother. 44:239-242.
21. Llop, C., J. Sala, M. D. Riba, and J. Guarro. 1999. Antimicrobial susceptibility testing of dematiaceous filamentous fungi: Effect of medium composition at different temperatures and times of readings. Mycopathologia 148:25-31.
22. Manavathu, E., U. Nune, K. Kanuri, P. H. Chandrasekar, and O. C. Abraham. 2000. Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus. Rev. Iberoam. Micol. 17:107-110.
23. Millikan, L. E. 2001. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients. Cutis 68:6-14.
24. Mock, M., M. Monod, F. Baudraz-Rosselet, and R. G. Panizzon. 1998. Tinea capitis dermatophytes: Susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology 197:361-367.
25. National Committee for Clinical Laboratory Standards. 1998. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi. Proposed standard M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
26. Niewerth, M., and H. C. Korting. 2000. The use of systemic antimycotics in dermatotherapy. Eur. J. Dermatol. 10:155-160.
27. Norris, H. A., B. Elewski, and M. A. Ghannoum. 1999. Optimal growth for the determination of the antifungal susceptibility of the three species of dermatophytes with the use of a microdilution method. J. Am. Acad. Dermatol. 40:S9-S13.
28. Perea, S., A. W. Fothergill, D. A. Sutton, and M. G. Rinaldi. 2001. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J. Clin. Microbiol. 39:385-388.
29. Porro, A. M., M. C. N. Yosioka, S. K. Kaminski, M. de A. Palmeira, O. Fischman, and M. Alchorne. 1997. Disseminated dermatophytosis caused by Microsporum gypseum in two patients with the acquired immunodeficiency syndrome. Mycopathologia 137:9-12.
30. Squeo, R. F., R. Beer, D. Silvers, I. Weitzman, and M. Grossman. 1998. Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host. J. Am. Acad. Dermatol. 39:379-380.
31. Szekely, A., E. M. Johnson, and D. W. Warnock. 1999. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J. Clin. Microbiol. 37:1480-1483.
32. Tsang, P., T. Hopkins, and V. Jimenez-Lucho. 1996. Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDS. J. Am. Acad. Dermatol. 34:1090-1091.
33. Walsh, T. J., and A. H. Groll. 1999. Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century. Transpl. Infect. Dis. 1:247-261.
34. Wildfeuer, A., H. P. Seide, I. Paule, and A. Haberreiter. 1998. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B, and griseofulvin. Mycoses 41:309-319.